Microbot Medical

MBOT · NASDAQ

$0.9475−$0.0053 (−0.56%)TodayMarket closed ·
Prev close $0.9528

About MBOT

Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The company is headquartered in Hingham, Massachusetts and currently employs 43 full-time employees. The company has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. The company specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. The company eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.

Employees
43
Headquarters
Hingham, Massachusetts
Listed
Mar 25, 1992
Sector
Health Care
Industry
Health Care Equipment & Supplies

Leadership

Microbot Medical executives
NameTitleSince
Harel Gadot—2016
Rachel Vaknin——
Simon Sharon——
Juan Diaz-Cartelle——
Scott Burell——
Prattipati Laxminarain——
Martin Madden——
Aileen Stockburger——
Tal Wenderow——
David Wilson——

Similar companies

Companies in the same industry as Microbot Medical

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.